相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib
Alejandro Garcia-Horton et al.
LEUKEMIA & LYMPHOMA (2021)
Risk of hepatitis B virus reactivation following ruxolitinib treatment in patients with myeloproliferative neoplasms
Ming-Hui Duan et al.
HEMATOLOGY (2021)
Risk of B-cell lymphoma in MPN patients treated with JAK1/2 inhibitors: Contradictory results?
Mariangela Costanza et al.
LEUKEMIA RESEARCH (2020)
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment
Harinder Gill et al.
ANNALS OF HEMATOLOGY (2019)
A journey through infectious risk associated with ruxolitinib
Emanuela Sant'Antonio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
Shruti Prem et al.
BLOOD RESEARCH (2019)
Infectious complications in patients on treatment with Ruxolitinib: case report and review of the literature
Maria Veronica Dioverti et al.
INFECTIOUS DISEASES (2018)
Ruxolitinib-associated infections: A systematic review and meta-analysis
Federico Lussana et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses
Srdan Verstovsek et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Occult hepatitis B infection reactivation after ruxolitinib therapy
Giovanni Perricone et al.
DIGESTIVE AND LIVER DISEASE (2017)
A life-threatening ruxolitinib discontinuation syndrome
Giacomo Coltro et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib
Keita Kirito et al.
INTERNAL MEDICINE (2016)
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations
Sabine Blum et al.
JOURNAL OF BLOOD MEDICINE (2016)
Immunological Consequences of JAK Inhibition: Friend or Foe?
Donal P. McLornan et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2015)
Hepatitis B virus reactivation associated with ruxolitinib
Chien-Heng Shen et al.
ANNALS OF HEMATOLOGY (2014)
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis
G. Caocci et al.
LEUKEMIA (2014)
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
Annkristin Heine et al.
BLOOD (2013)
Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
Rowan Wathes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Current trends in management of hepatitis B virus reactivation in the biologic therapy era
Claudio M. Mastroianni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
分享论文
